doi: 10.1136/bmj.291.6499.900-a.
Antisecretory drugs and gastric cancer
- PMID: 2864976
- PMCID: PMC1416710
- DOI: 10.1136/bmj.291.6499.900-a
Item in Clipboard
Antisecretory drugs and gastric cancer
Br Med J (Clin Res Ed).
.
No abstract available
Similar articles
-
Inhibition of acid and gastric carcinoids.Gut. 1985 Dec;26(12):1279-83. doi: 10.1136/gut.26.12.1279. Gut. 1985. PMID: 2867953 Free PMC article. Review. No abstract available.
-
Untoward reactions to gastric antisecretory drugs.Ital J Gastroenterol. 1992 Oct;24(8):470-1. Ital J Gastroenterol. 1992. PMID: 1358265 No abstract available.
-
Antisecretory drugs and gastric cancer.Br Med J (Clin Res Ed). 1985 Dec 7;291(6509):1646-7. doi: 10.1136/bmj.291.6509.1646-c. Br Med J (Clin Res Ed). 1985. PMID: 3935223 Free PMC article. No abstract available.
-
[Comparative antisecretory activity of famotidine, omeprazole, and rabeprazole (pariet) in ulcer disease based on daily pH-monitoring].Voen Med Zh. 2001 Sep;322(9):54-8. Voen Med Zh. 2001. PMID: 11668793 Clinical Trial. Russian. No abstract available.
-
[Adverse effects of gastric acid suppressive drugs].Nihon Rinsho. 2007 Oct 28;65 Suppl 8:198-201. Nihon Rinsho. 2007. PMID: 18074539 Review. Japanese. No abstract available.
Cited by
-
Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.Drugs. 1986 Jul;32(1):15-47. doi: 10.2165/00003495-198632010-00002. Drugs. 1986. PMID: 3527658 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical